Matthew Gline
Chief Executive Officer, Roivant.
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Roivant ROIV16,659,945 shares3$583.2M at $35.01Jun 30, 2026
Arbutus Biopharma ABUS38,847,462 shares4$166.5M at $4.29Mar 6, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2026Shares withheld for tax 76,171 shares at $35.39 of Roivant3
- Apr 16, 2026Sold 289,774 shares at $29.16 of Roivant5
- Mar 31, 2026Shares withheld for tax 304,684 shares at $27.70 of Roivant6
- Mar 30, 2026Shares withheld for tax 53,826 shares at $26.41 of Roivant6
- Mar 30, 2026Exercised options 97,319 shares of Roivant6
- Dec 15, 2025Other 1,329,325 shares at $21.68 of Roivant7
- Dec 15, 2025Sold 943,527 shares at $21.68 of Roivant7
- Dec 15, 2025Exercised options 2,272,852 shares at $12.68 of Roivant7
- Dec 15, 2025Other 797,595 shares at $21.68 of Roivant7
- Dec 15, 2025Sold 566,116 shares at $21.68 of Roivant7
- Dec 15, 2025Exercised options 1,363,711 shares at $12.68 of Roivant7
- Dec 15, 2025Other 3,739 shares at $21.68 of Roivant7
- Dec 15, 2025Sold 230,357 shares at $21.68 of Roivant7
- Dec 15, 2025Exercised options 234,096 shares at $4.06 of Roivant7
- Sep 18, 2025Bought 3,315 shares at $15.07 of Roivant8
- May 20, 2025Shares withheld for tax 10,945 shares at $11.04 of Roivant9
- Apr 20, 2025Shares withheld for tax 10,945 shares at $10.15 of Roivant10
- Mar 20, 2025Shares withheld for tax 10,945 shares at $10.97 of Roivant11
- Feb 20, 2025Shares withheld for tax 10,945 shares at $10.72 of Roivant12
- Jan 20, 2025Shares withheld for tax 11,623 shares at $11.15 of Roivant13
- Dec 20, 2024Shares withheld for tax 10,945 shares at $11.57 of Roivant14
- Nov 20, 2024Shares withheld for tax 10,945 shares at $11.49 of Roivant15
- Oct 20, 2024Shares withheld for tax 10,945 shares at $11.92 of Roivant16
- Sep 23, 2024Other 498,539 shares at $11.97 of Roivant17
- Sep 23, 2024Sold 1,983,257 shares at $11.79 of Roivant17
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARRoivant, Board member
- 2SEC EDGARArbutus Biopharma, Board member
- 3
- 4
- 5SEC EDGARForm 4 filed Apr 20, 2026
- 6SEC EDGARForm 4 filed Apr 1, 2026
- 7SEC EDGARForm 4 filed Dec 17, 2025
- 8SEC EDGARForm 4 filed Sep 18, 2025
- 9SEC EDGARForm 4 filed May 22, 2025
- 10SEC EDGARForm 4 filed Apr 22, 2025
- 11SEC EDGARForm 4 filed Mar 24, 2025
- 12SEC EDGARForm 4 filed Feb 24, 2025
- 13SEC EDGARForm 4 filed Jan 22, 2025
- 14SEC EDGARForm 4 filed Dec 26, 2024
- 15SEC EDGARForm 4 filed Nov 22, 2024
- 16SEC EDGARForm 4 filed Oct 22, 2024
- 17SEC EDGARForm 4 filed Sep 24, 2024